Menu
Not yet recruiting NCT07264348

Cardiometabolic and Hormonal Adaptations to 4-Month Zumba Training in Overweight/Obese Women

No phase Interventional Hormone Cardiovascular Obesity & Overweight

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Zumba training.
Who it may be relevant to
Registry conditions: Hormone, Cardiovascular, Obesity & Overweight. Basic parameters: 18 years — 65 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effects of a 4-month Intervention on Cardiometabolic, Hormonal, Inflammatory, Liver, Renal, Electrolyte, and Muscle Enzyme Parameters in Pre- and Post-Menopausal Overweight and Obese Women: A Randomized Controlled Trial

Overview

This study aims to evaluate the effects of a 4 month Zumba training program on cardiometabolic, hormonal, inflammatory, hepatic, renal, and functional parameters in overweight and obese women. Participants will be classified according to menopausal status (pre- or post-menopausal) and randomly assigned to an exercise group or a non-exercise control group.

Detailed description

Overweight and obesity are associated with metabolic dysregulation, hormonal imbalance, chronic inflammation, and reduced physical capacity. Zumba training is a dance-based aerobic exercise that can improve cardiovascular fitness, energy expenditure, and adherence to physical activity programs.

This study will assess the effects of a 4 month Zumba training program (4 sessions per week, 60 minutes per session) on: Body composition and anthropometric measures, Aerobic capacity, Hormonal profile, Lipid profile, Inflammatory biomarkers, Liver enzymes, Renal function markers, Electrolytes, Muscle enzymes, Pre- and post-training measurements will be taken under standardized conditions.

Interventions

  • Behavioral Zumba training
    Participants assigned to the experimental groups will perform a supervised Zumba training program for 10 weeks, with 4 sessions per week, each session lasting 60 minutes. Sessions will include a standardized warm-up (10 minutes), choreographed dance-based aerobic sequences performed at moderate intensity (40 minutes), and a cool-down with stretching (10 minutes).

Primary outcome measures

  • Body Mass Index (BMI) [Time frame: Baseline and after 4 months of Zumba intervention.]
  • Body Fat Percentage [Time frame: Baseline and after 4 months of Zumba intervention.]
  • Waist Circumference [Time frame: Baseline and after 4 months of Zumba intervention.]
  • Waist-Hip Ratio [Time frame: Baseline and after 4 months of Zumba intervention.]
  • Hip Circumference [Time frame: Baseline and after 4 months of Zumba intervention.]
  • Prolactin [Time frame: Baseline and after 4 months of the intervention.]
  • Testosterone [Time frame: Baseline and after 4 months of the intervention.]
  • Cortisol [Time frame: Baseline and after 4 months of the intervention.]
  • Progesterone [Time frame: Baseline and after 4 months of the intervention.]
  • Estradiol [Time frame: Baseline and after 4 months of the intervention.]
Secondary outcome measures (3)
  • Resting Heart Rate [Time frame: Baseline and after 4 months of Zumba intervention.]
  • Blood Pressure (Systolic and Diastolic) [Time frame: Baseline and after 4 months of Zumba intervention.]
  • 6-Minute Walk Test (6MWT) Distance [Time frame: Baseline and after 4 months of Zumba intervention.]

Eligibility criteria

Inclusion criteria

  • Female, aged 18-65 years
  • BMI ≥ 25 kg/m²
  • Pre-menopausal or post-menopausal (classified clinically)
  • Voluntary written informed consent

Exclusion criteria

  • Hormonal therapy or weight-loss medications
  • Endocrine diseases or chronic illness
  • Recent intense physical training (<48 hours before baseline)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07264348 · HORMONE-2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗